Can multiple mycotoxins and zearalenone amplify hormone and immune burden?

Multiple mycotoxins and xenoestrogens disrupt systemic homeostasis through interconnected immunological, endocrine, and gastrointestinal pathways, which is particularly relevant for maintaining metabolic and hormonal resilience.

Synergistic toxicological and estrogenic burden

• Oxidative and inflammatory cascades: Co-exposure to mycotoxins (such as deoxynivalenol, aflatoxins, and patulin) synergistically elevates reactive oxygen species (ROS), depletes cellular glutathione, and induces lipid peroxidation. This oxidative stress activates NF-κB and MAPK pathways, triggering a self-reinforcing pro-inflammatory cytokine cascade marked by elevated TNF-α and IL-6.
• Endocrine disruption: Zearalenone (ZEN) acts as a direct agonist of estrogen receptors (ER-α, ER-β) and G-protein-coupled estrogen receptors (GPER). Although its direct binding affinity is $10^3$ to $10^4$ times weaker than $17\beta$-estradiol (with IC50 values of 160 to 240 nM), its active metabolite, $\alpha$-zearalenol, approaches or matches estradiol's potency, driving robust downstream endocrine signaling.

Enterohepatic reactivation and clearance

• Detoxification failure: Phase II UDP-glucuronosyltransferase (UGT) enzymes normally conjugate active estrogens and ZEN into inactive, water-soluble glucuronides for excretion. Slower host detoxification limits this primary clearance barrier, leaving the system vulnerable to re-toxification.
• Microbiome-driven recirculation: In patients with gut dysbiosis—which ZEN itself can promote by shifting microbiota toward pro-inflammatory taxa—there is an enrichment of bacterial taxa expressing $\beta$-glucuronidase. These enzymes deconjugate inactive glucuronides in the gut, regenerating free, active xenoestrogens and toxins. This process facilitates their reabsorption via enterohepatic circulation, amplifying systemic estrogenic signaling and local hepatic/intestinal inflammatory burdens.

Bottom line

• Impaired host phase II detoxification and $\beta$-glucuronidase-mediated gut dysbiosis act synergistically to prevent the clearance of mycotoxins like zearalenone, recycling active endocrine disruptors and inflammatory drivers back into systemic circulation to compound hormonal and immune strain.